Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
58%
Total
Publications
222
Total Open
Publications
128
Total
Citations
8.3K
Open Access
Percentage
58%
Total
Publications
222
Total Open
Publications
128
Total
Citations
8.3K
Breakdown
Publisher Open
18%
Both
29%
Other Platform Open
11%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
33
Hybrid 51%
52
No Guarantees 17%
18
Other Platform Open
Domain 77%
68
Institution 42%
37
Preprint 11%
10
Public 9%
8
Other Internet 7%
6
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 68 |
Europe PMC | Domain | 35 |
DOI | Other Internet | 16 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 14 |
University College London - UCL Discovery | Institution | 8 |
bioRxiv | Preprint | 6 |
Figshare | Public | 5 |
Semantic Scholar | Public | 4 |
Imperial College London - Spiral | Institution | 4 |
whiterose.ac.uk OAI-PMH Repository | Institution | 3 |